Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Annexon, Inc. | 55,000 | reported | 05 Jun 2025 | tx 5+167,000 |
| CNS Pharmaceuticals, Inc. | 1,517 | reported | 17 Nov 2025 | tx 8+79,442 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 17 Nov 2025 | GRANT_AWARD | CNS Pharmaceuticals, Inc. | 1,517 | 0.00 USD | deriv |
| 05 Jun 2025 | GRANT_AWARD | Annexon, Inc. | 55,000 | 0.00 USD | deriv |
| 05 Jun 2024 | GRANT_AWARD | Annexon, Inc. | 44,000 | 0.00 USD | deriv |
| 08 Apr 2024 | GRANT_AWARD | CNS Pharmaceuticals, Inc. | 17,500 | — | deriv |
| 08 Apr 2024 | GRANT_AWARD | CNS Pharmaceuticals, Inc. | 17,500 | — | deriv |
| 21 Sept 2023 | GRANT_AWARD | CNS Pharmaceuticals, Inc. | 16,551 | — | deriv |
| 08 Jun 2023 | GRANT_AWARD | Annexon, Inc. | 24,000 | 0.00 USD | deriv |
| 05 May 2023 | GRANT_AWARD | CNS Pharmaceuticals, Inc. | 8,300 | — | deriv |
| 09 Jun 2022 | GRANT_AWARD | Annexon, Inc. | 24,000 | 0.00 USD | deriv |
| 19 Jan 2022 | GRANT_AWARD | Annexon, Inc. | 20,000 | 0.00 USD | deriv |